Better Together: #Cannabis-Infused #Beer JV’s Ready Themselves for October Legalization (CSE: $SPR.C) (OTCQB: $SRUTF) (NYSE: $CGC) (TSXV: $BEER.V) (NYSE: $HEXO)

Better Together: #Cannabis-Infused #Beer JV’s Ready Themselves for October Legalization (CSE: $SPR.C) (OTCQB: $SRUTF) (NYSE: $CGC) (TSXV: $BEER.V) (NYSE: $HEXO)

Point Roberts WA, Delta, BC – April 30, 2019 - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at cannabis-infused beer JV’s and distribution partnerships as they ready themselves for the upcoming Canadian consumables market, as regulations are expected to permit this October.

Read this in full at https://www.investorideas.com/news/2019/cannabis/04304Stocks-Beer.asp

Recently one of the largest cannabis beverage partnerships involving Canopy Growth Corp. (NYSE:CGC) (TSX: WEED) and Constellation Brands, Inc. announced that they have agreed to make some changes to various warrants and rights.

The new agreement to change some of the warrants and rights that influence their partnership is believed to have been influenced by Canopy’s plans to acquire Acreage Holdings Inc. Another key factor that influenced the decision by Constellation Brands and Canopy Growth to review the warrants and rights is the chance of cannabis legalization by the federal government.

The attention surrounding cannabis-infused beers is bringing in new players such as Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF), and Moosehead Breweries Limited, who just announced that they have entered into a definitive agreement to form an exclusive joint venture to develop, produce, and market cannabis-infused beverages in Canada using Sproutly’s acquired proprietary, naturally produced water-soluble cannabinoids known as Infuz2O. 

Moosehead, the oldest and largest Independent Beer Company in Canada, brings over 152 years of beverage experience in building and operating adult beverage businesses in Canada, an established national supply chain and distribution capabilities in all provinces with a large sales and marketing team  and the Oland family’s proven ability in building and marketing industry leading adult beverage brands such as Moosehead and licensed and supporting brands such as Alexander Keith’s, Angry Orchard and Twisted Tea.

Sproutly’s Infuz2O can deliver the cannabis effect within 5 minutes and last up to 90 minutes, providing a similar experience timeframe to beer, while also producing a clear cannabis beverage that is much easier and faster to formulate than many of its competitors who will be using emulsifiers, encapsulation or chemically modified techniques to strangely mirror solubility.

“With the anticipated legalization of edibles in Canada later this year, Moosehead has made the strategic decision to enter the cannabis beverage market. As one of the oldest brands in Canada and a leader in the beer category, we believe we are uniquely positioned to be a leader in the cannabis beverage category.” said Andrew Oland, Chief Executive Officer of Moosehead. “As a 152 year old company spanning six generations, we are very selective about new business opportunities. After a significant amount of due diligence on Sproutly’s APP technology and Infuz₂O water soluble cannabinoids vs other competitive technologies, we are excited to announce this joint venture. With their advanced technology and our long-standing product development experience, we expect to bring to Canadian consumers cannabis beverages that address the major issues currently limiting appeal of this category in other markets; a beverage that: 1) actually tastes good; and 2) provides an immediate and controllable cannabis experience lasting up to 90 minutes.”

 “After careful analysis of the cannabis industry and the cannabis beverage opportunity in Canada, we believe that Moosehead and Sproutly together are well positioned to become a significant player in the category.” said Matthew Oland, incoming Chief Executive Officer of the Joint Venture. “The JV’s ability to leverage Moosehead’s rich history of building adult-beverage brands, and its established R&D and operational infrastructure, will enable the JV to bring great tasting cannabis beverages to Canadian consumers. The Infuz₂0 technology delivers a natural cannabis beverage experience, with an onset and offset time similar to traditional flower cannabis, without the need for chemical modification. We believe this will be a game changer for the sector.”

Lexaria Bioscience Corp., who develops and licenses DehydraTECH, a patented lipid nutrient infusion technology that improves taste, rapidity, and delivery of bioactive compounds that include cannabinoids, vitamins, NSAIDs, nicotine, and other molecules, has also been looking into the beverage sector for quite some time, having partnered with Hill Street Beverage Company Inc. (TSX-V:BEER) (OTC: HSEEF)

Hill Street CEO Terry Donnelly recently discussed the company’s first quarter which showed the company’s revenue was up 100 percent YOY and the company is tracking 35 percent annual revenue growth for 2019. Donnelly also discussed how Hill Street has used its line of non-alcoholic beer and wine to drive its brand recognition ahead of the legalization of infused beverages in the fall. Hill Street uses Lexaria’s DehydraTECH to create infused beverages which allows for 5 to 10 percent greater availability of THC and ensures consumers feel the beverage’s full effect in 15 minutes.

A sleeping giant in this same sector that is surrounded by market anticipation is Truss, the JV of Molson Coors Canada, the Canadian business unit of Molson Coors Brewing Company, and HEXO Corp. (NYSE: HEXO) (TSX: HEXO) who announced their partnership back in August 1, 2018, to develop non-alcoholic, cannabis-infused beverages for the Canadian market following legalization.

“With the backing of two partners with deep Canadian roots, proven success, and market-leading experience in the respective beverage and cannabis industries in Canada, Truss will hit the ground running,” said Brett Vye, Chief Executive Officer at Truss. “When consumable cannabis is legalized in Canada, Truss will be ready to make its mark as a responsible leader in providing high-quality beverages for the Canadian consumer.  Why “Truss”? We are joining together the extensive experience and excellent practices of each partner to build a powerful foundation for the future.”

This combination of experienced beverage providers with cannabis technology companies allows for all of these companies to have the best of both worlds. As these JV’s ready themselves for October the only big question is what the finalized regulations will permit and how these companies may have to alter their approach to match them.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

https://www.investorideas.com/About/

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: this news article featuring  Sproutly Inc (SPR)  is a paid for news release on Investorideas.com – third party.

Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Contact Investorideas.com

800-665-0411

Get more Marijuana, hemp & cannabis stock investor ideas- news, articles, podcasts and stock directories

Better Quality & Innovation Continue in #CBD #Pets Products Coming to Market (TSX: $WEED.TO) (NYSE: $CGC) (OTC: $LRSV) (OTC: $MJNA) (TSXV: $EAST.V)

Better Quality & Innovation Continue in #CBD #Pets Products Coming to Market (TSX: $WEED.TO) (NYSE: $CGC) (OTC: $LRSV) (OTC: $MJNA) (TSXV: $EAST.V)

Point Roberts WA and Delta BC - April 30, 2019 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at how as the CBD pet market grows, more companies are putting in extra effort to create quality products and innovative technologies to ensure the best care possible for pets that are often considered family members by consumers.

A recent study published in The Pet Behavior Science Journal indicates that dogs with epilepsy can have less frequent seizures if treated using CBD oil.

While the study may have been small because it only followed three dogs over a period of two months while those dogs were treated with CBD oil, the research suggests that dogs respond to cannabis treatment in the same way that humans do.

Read this in full at https://www.investorideas.com/news/2019/cannabis/04301CBDPetProducts.asp

One of the largest cannabis companies in the world, Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) and Sequential Brands Group, Inc. announced back in February that Martha Stewart had joined the Company in an advisory role to assist with developing and positioning a broad new line of product offerings across multiple categories, with a focus on pet products.

“I am delighted to establish this partnership with Canopy Growth and share with them the knowledge I have gained after years of experience in the subject of living,” said Martha Stewart. “I’m especially looking forward to our first collaboration together, which will offer sensible products for people’s beloved pets.”

While we are still waiting with baited breath for more news and developments on Canopy’s pet product line, the company is not sitting idly by and is ensuring proper supply arrangements so as to be prepared to enter the market. More recently, the company announced its acquisition of AgriNextUSA, a hemp enterprise led by CEO Geoff Whaling, which has been at the forefront of hemp advocacy and building a vibrant hemp sector in the US. The acquisition will accelerate Canopy Growth’s entry into key American jurisdictions as regulations surrounding the full use of hemp as a crop begin to be implemented, thanks in part to the recently enacted 2018 US Farm Bill.

Hemp has the potential to disrupt several prominent industries: advanced materials, cosmetics, energy, fiber and textiles, food and protein production and the health and wellness sectors. In addition, hemp is a natural source of CBD, the non-intoxicating component of cannabis that can be used for health and wellness purposes, as well as pet products in jurisdictions where legally permitted.

LinkResPet, a subsidiary of Link Reservations Inc. (OTC: LRSV), a company providing CBD products especially tailored for pets, has recently announced that it is finalizing negotiations with a certified US-based CBD producer and fulfillment center and are currently in the final stage of negotiations.

Link Reservations Inc. is looking to establish itself in the US/North American market and has been communicating with various producers in order to find partners that meet their high standards, and has now found such a producer to advance on their first partnership.

Upon this arrangement being successfully completed and as the company explores retail opportunities, LRSV will be able to offer home delivery of its CBD pet products in the US and Canada. The company will also be in a position to supply products to brick & mortar pet retailers. This will be a key for future growth as the LinkResPet product line increases.

René Lauritsen, Link Reservations Inc. CEO commented: “This is a huge step for LRSV and our brand LinkResPet, and we are incredibly excited to be making advances in North America. We selected our new partner due to their high-grade CBD products and flexibility in production and delivery timeframes. We ensure our products undergo a rigorous process of quality control and testing, using the latest scientific methods that will confirm their quality and safety, which of course includes being free of bacteria, pesticides, mold, solvents, and other contaminants."

The producer is specialized in “SFE” technique (Supercritical Fluid Extraction), using state of the art equipment. “SFE/CO2 Extraction” is the most sophisticated method of professionally producing hemp oil extract, gently obtaining the extract and preserving many of the plant’s active molecules, while being environmentally friendly and sustainable. In this process, supercritical CO2 (carbon dioxide) gas is used in natural product extraction, offering the possibility to separate materials from each other selectively and with great care.

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States’ subsidiary, Phyto Animal Health recently announced the launch of its newest CBD pet product, HempBone Smoked Salmon Bites for cats.

HempBone Smoked Salmon Bites are artisanal star-shaped cat treats that are soft-baked and naturally-flavored to taste like smoked salmon and roasted seafood.

Small cats can enjoy three to four bites daily to help support overall wellness, while larger cats may require a larger serving. CBD has been studied extensively by top-veterinarians to promote cardiovascular function, support healthy joints, and promote neurological health and emotional behavior in pets.

"Our HempBone Bacon Apple Donuts have gained incredible popularity over the past year because of their natural allergen-free ingredients and palatable taste that dogs love," said Phyto Animal Health CEO, Ian Quinn. "We wanted to offer a safe and nutritious snack for cats as well so we created HempBone Smoked Salmon Bites. They are one-fourth of the CBD per serving size as the Bacon Apple Donuts and feature a more feline-focused flavor, better meeting the dosing needs and taste preferences of cats."

"There is currently an upward trend in the CBD pet supplement industry and for good reason," said Medical Marijuana, Inc. CEO, Dr. Stuart Titus. "Phyto Animal Health leads this industry trend with premium quality, veterinarian-recommended CBD supplements in a variety of options that are customized to meet the needs of pets of many different sizes and species."

EastWest Bioscience Inc. (TSX-V: EAST) is also bringing new innovative products to market, having announced four additional products to its Natural Pet Science line, both in Canada and the US, with CBD included in the US destined products which will be marketed to CBD permitted jurisdictions.

Overshadowed by the significance of the CBD opportunity that the signing of the 2018 Farm Bill presented, in December 2018, The US Food and Drug Administration completed its evaluation of three generally recognized as safe (GRAS) notices for hemp seed-derived food ingredients. These ingredients being hulled hemp seed (GRN765), hemp seed protein powder (GRN771) and hemp seed oil (GRN778). These notices represent a real market opportunity for EastWest, which validates the Company's Canadian ‘product first' strategy.

EastWest's product development and sales strategy in the US will be similar to what it used to grow retail shelf space in Canada. Now that there is FDA approval for hemp-based foods, the Company's interesting and innovative hemp-based products with unique formulations and ingredients become attractive to distributors. As Eastwest's hemp products become established in retail stores and distribution networks it lowers the barrier of entry for the Company's CBD infused products.

"Hemp based products are still relatively new to US markets and distributors are always looking for innovative lines to sell. Our Hemp and Cricket pet treats on shelves in the US, even without CBD, represents an opportunity to increase revenues beyond what the Canadian market is capable of," states Rodney Gelineau, CEO of EastWest Bioscience Inc.

August 2018 figures from New Frontier Data found that hemp-derived pet supplies generated $13 million in 2017 and by 2022 it's expected that this number will reach upwards of $125 million.

Currently dogs and cats are the focus of the day as these are our most common North American pets, however as companies develop better quality products and increase distribution, we can expect to see horses and larger animals as beneficiaries of CBD as well, expanding the overall potential for the market. As more research comes out on the benefits of CBD for animals, we can look ahead to more companies entering the market, with companies having early entry in the sector gaining the lead.

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com - News that Inspires Big Investing Ideas

https://www.investorideas.com/About/

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.  Disclosure: this article featuring  Link Reservations Inc. (LVSR)  is a paid for service on Investorideas.com – third party. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Contact Investorideas.com

800-665-0411

Get more Marijuana, hemp & cannabis stock investor ideas- news, articles, podcasts and stock directories

Breaking #Payment News- Nxt-ID, Inc. (NASDAQ: $NXTD) Announces Filing of Form 10 Registration Statement for Planned Spin-Off of its Payments Business

Breaking #Payment News- Nxt-ID, Inc. (NASDAQ: $NXTD) Announces Filing of Form 10 Registration Statement for Planned Spin-Off of its Payments Business

SEBASTIAN, Florida, April 30, 2019 – (Investorideas.com Newswire) Nxt-ID, Inc. (NASDAQ: NXTD) today announced that a Form 10 Registration Statement was filed with the U.S. Securities and Exchange Commission in connection with the planned spin-off of its payments, authentication and credential management business (the “Payments Business”). The Form 10 Registration Statement is used to register a class of securities that are intended to be traded publicly and is subject to review and approval of the Securities and Exchange Commission.

Read this in full at https://www.investorideas.com/CO/NXT/news/2019/04301Form10-PaymentsBusiness.asp

“This filing marks an important next step in the planned spin-off of our Fit Pay, Inc. (“Fit Pay”) subsidiary and our payments business,” said Chief Executive Officer Gino Pereira. “The spin-off will create two independent companies focused on delivering significant ongoing value to our shareholders within their respective markets.”

Nxt-ID (or the “Company”) previously announced that it intends to separate its payments, authentication and credential management business into an independent company and distribute those shares to Nxt-ID shareholders through the execution of a spin-off, which it believes will qualify as a tax-free distribution. Immediately following the transaction, Nxt-ID shareholders, who own shares of Nxt-ID on the spin-off Record Date, which has not yet been announced, will own shares of both companies. The new company, PartX, Inc. (“PartX”), will include the assets acquired in the May 2017 business combination with Fit Pay, Inc. as well as the payment, authentication and credential management assets the Nxt-ID developed previously.

“This spin-off will enable both companies to execute business plans that leverage their core strengths and to present clear, well-defined value proposition for our shareholders, partners and customers,” said Michael Orlando, COO of Nxt-ID, president of Fit Pay, Inc. and incoming Chief Executive Officer of PartX, Inc. “This more singular focus, along with a more concentrated and efficient use of resources, will fully empower both companies to maximize shareholder value.”

The Company believes the spin-off will provide a number of benefits, including: (1) enhanced strategic and management focus on the core business and growth of each company; (2) more efficient capital allocation, direct access to capital and expanded growth opportunities for each company; (3) improved investor understanding of the business strategy and operating results of each company; and (4) enhanced investor choice by offering investment opportunities in separate entities.

PartX, Inc. 

The new company, PartX, will include the payment, authentication and credential management assets of Nxt-ID and Fit Pay, Inc, including Fit Pay's Token Requester Platform, which enables cardholders to securely add their payment credentials to devices that are integrated with Fit Pay's token management solution. The Platform allows device manufacturers, merchants, banks and any other entities making digital transactions to offer their customers a safe and convenient payment experience. FitPay is one of the first successfully commercialized token requestor service providers to be integrated with the major payment card networks.

PartX's core capabilities also include the development of payment and authentication devices that leverage NFC (near field communication), cryptocurrency, and blockchain technology. It is currently developing secure, connected devices that are focused on digital payments and loyalty programs, which will be distributed through partnerships and offered direct to consumers. The assets of the new company will include a portfolio of payment, authentication and blockchain technology patents that have been filed by or issued to Nxt-ID and Fit Pay.

Nxt-ID and LogicMark 

Assets associated with Nxt-ID's healthcare subsidiary, LogicMark, LLC, will remain with the Company along with the assets under 3D-ID, LLC. LogicMark produces a range of products within the personal emergency response system (PERS) market. The Company has differentiated itself by offering non-monitored products, which only require a one-time purchase price, instead of a recurring monthly contract, offering a significant value proposition over monitored solutions.

Transaction Details 

The registration statement may be accessed at www.sec.gov under the name PartX, Inc., the new corporate name for the parent company of the Payments Business. The registration statement provides information regarding the business, strategy, and historical financial results of PartX, as well as further details on the anticipated terms of separation and distribution and tax matters agreements between Nxt-ID and PartX in connection with the planned spin-off. PartX expects to update its registration statement in subsequent amendments as additional information is finalized prior to the spin-off.

The spin-off of this business is subject to final approval by the Nxt-ID Board of Directors, execution of transition services and assignment agreements, arrangement of financing facilities, the effectiveness of the registration statement, and other customary conditions. The separation will not require a shareholder vote and is expected to be completed in the second quarter of 2019. PaxtX has applied to list on the OTCQB of the OTC Markets Group Inc. Following the spin-off, Nxt-ID will continue to trade on the Nasdaq Capital Market under the symbol “NXTD.”

About Nxt-ID, Inc.

Nxt-ID, Inc. (NASDAQ: NXTD) provides a comprehensive platform of technology products and services that enable the Internet of Things (IoT). With extensive experience in access control, biometric and behavior-metric identity verification, security and privacy, encryption and data protection, payments, miniaturization and sensor technologies, Nxt-ID develops and markets groundbreaking solutions for payment and IoT applications. Its industry-leading technology products and solutions include MobileBio®, a suite of biometric solutions that secure consumers' mobile platforms, the Wocket™, a next-generation smart wallet and the Flye, a digital credit card developed in collaboration with WorldVentures.  

Nxt-ID includes three mobile and IoT-related subsidiaries: LogicMark, LLC, a manufacturer and distributor of non-monitored and monitored personal emergency response systems ("PERS") sold through dealers/distributors and the United States Department of Veterans Affairs; Fit Pay, Inc., a proprietary technology platform that delivers end-to-end solutions to device manufacturers for contactless payment capabilities, credential management, authentication and other secure services within the IoT ecosystem, and 3D-ID LLC, which is engaged in biometric identification and authentication. Learn more about Nxt-ID at www.nxt-id.com. Fit Pay and the Fit Pay Payment Platform are the sole property of Fit Pay, Inc. For Nxt-ID Inc. corporate information contact: info@nxt-id.com

Forward-Looking Statements for Nxt-ID: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.

There are a number of important factors that could cause the Company's actual results to differ materially from those indicated by such forward-looking statements, including whether the planned spin-off of the payments business is completed, as expected or at all, and the timing of any such spin-off; whether the conditions to the spin-off can be satisfied; whether the operational, marketing and strategic benefits of the spin-off can be achieved; whether the costs and expenses of the spin-off can be controlled within expectations; and general market and economic conditions. The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from our expectations in any forward-looking statement. Investors should consider this cautionary statement, as well as the risk factors identified in our periodic reports filed with the SEC, when evaluating our forward-looking statements.

Media Contacts:

Chris Orlando

chris.orlando@nxt-id.com

+1-760-468-7273

D. Van Zant

+1-800-665-0411

press@nxt-id.com

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: NXTD is a paid news, social media and PR client on Investorideas.com More info https://www.investorideas.com/About/News/Clientspecifics.asp

Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp  Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

NXT-ID, Inc. (NASDAQ:NXTD)

is a Featured tech company on Investorideas.com

Visit Profile page: https://www.investorideas.com/CO/NXT/

Get News Alerts on NXT-ID, Inc.

  

Get more tech stocks investor ideas- news, articles, podcasts and stock directories

Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (TSXV: $ZENA.V) (CSE: $HITI.C) (OTCQB: $HITIF)(TSXV: $KHRN.V) (OTCQB: $KHRNF)

Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (TSXV: $ZENA.V) (CSE: $HITI.C) (OTCQB: $HITIF)(TSXV: $KHRN.V) (OTCQB: $KHRNF)

Delta, Kelowna, BC –April 29th, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcasts^CM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2019/042919-StocksToWatch.mp3

Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/04291ZENA-HITI-HITIF-KHRN-KHRNF.asp

Hear Investor ideas cannabis potcast on iTunes  

Today’s podcast overview/transcript:

Good morning and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today’s podcast begins with an introduction of myself, Taylor Van Zant the host of our “potcasts” and after that I focus on a few early announcements from a few interesting companies.

Khiron Life Sciences Corp. (TSXV: KHRN), (OTCQB: KHRNF), an integrated cannabis company with its core operations in Latin America, announced today that the Company has signed an LOI with Copservir Ltda., Colombia's largest pharmacy chain, to distribute Khiron's medical cannabis products across the country. The companies have agreed to initial discounting and commercial fees and will work towards establishing a definitive commercial contract and detailed distribution plan to begin sales in the second half of 2019.

As Colombia's largest pharmacy chain, Copservir Ltda., operates over 900 stores across 200 cities and municipalities with a traditional brick and mortar presence representing 75% of its CAD 500 Million / year sales. In addition, a growing virtual presence represents 25% of its sales with an annual growth rate of over 20%. The company combines its retail and virtual presence with a strong distribution and logistics platform with four distribution centres in the main cities of Colombia and a home delivery service in 120 cities. This makes the Colombian Government-administered company the largest by store-count pharmacy chain in the country.

On completion of the agreement, Khiron will have established a compliant and secure distribution platform for its medical products across Colombia, starting with its custom-made pharmacy compound strategy. Copservir's extensive brick-and-mortar presence, virtual channel and distribution capability will allow Khiron to offer patients across the country the option for pick-up or home delivery of their medical cannabis formulations. Coupled with Khiron's ongoing medical education platform to educate and engage doctors and physicians across the country, this distribution strategy will allow Khiron to reach more patients in a safe, compliant and innovative matter.

Alvaro Torres, Khiron CEO and Director commented, "The proposed agreement with Copservir Ltda. represents a significant development for Khiron, offering the opportunity to leverage our first mover advantage to distribute medical cannabis products across Colombia and service the more than 5 million potential patients in the country. We also view Copservir entering the medical cannabis market as a milestone validation of the market opportunity in Colombia. By offering a platform that makes it easier for patients to access their formulations in a compliant and safe manner, Khiron establishes a leadership position in the medical cannabis market in Colombia."

The companies will work towards establishing definite commercial and distribution agreements to begin sales in the second half of 2019.

High Tide Inc. (CSE:HITI) (OTCQB:HITIF), an Alberta-based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, announced that on Friday, April 26, 2019 the Alcohol and Gaming Commission of Ontario ("AGCO") approved and issued a Retail Operator Licence to High Tide's counterparty Dana Michele Kendal for the Canna Cabana Toronto store.  A Retail Store Authorization will also be required to be issued by the AGCO for the Winner to finalize the set-up of the Toronto Store. The Winner is aiming to open Canna Cabana Toronto on or before June 1, 2019.

The Toronto Store is expected to be highest profile Canna Cabana-branded location in Canada. "From originally being selected by the Winner to help establish the Toronto Store, to achieving this important milestone part-way through the process, we are growing very keen to open this shop near the intersection of Yonge Street and College Street," said Raj Grover, President and Chief Executive Officer of High Tide. "High Tide's best efforts are being put toward this project and we look forward to the privilege of the Toronto Store becoming a part of the surrounding community for the long term," added Mr. Grover.  Prior to opening the Toronto Store, the AGCO will conduct a pre-opening inspection to ensure that the Winner is ready to sell cannabis products to the public in accordance with the regulations and standards for cannabis retail stores.

Zenabis Global Inc. (TSXV: ZENA) (OTC:ZBISF)  announced that it has entered into a binding term sheet for a three-year supply arrangement with leading German pharmaceutical research company Farmako GmbH for: (1) the supply of biosynthetically produced pure CBD isolate oil (99.9%) from Farmako to Zenabis for sale in Canada; and (2) the supply of European Union Good Manufacturing Practices certified cannabis cultivated in Zenabis' indoor facilities in Canada for sale by Farmako to the German medical market.

Andrew Grieve, Chief Executive Officer of Zenabis, stated, "While Zenabis is committed to producing both hemp- and cannabis-derived CBD products, we are thrilled to have signed the very first commercial agreement globally of its kind for the purchase of biosynthetic cannabinoids.  We are purchasing the CBD isolates from Farmako at an incredibly low cost, which will allow us to tap into the rapidly growing Canadian CBD market by supplying products that will be priced much more competitively than current market offerings. This partnership will also enable Zenabis to supply high-quality medical cannabis into Germany, one of the largest medical cannabis markets in the world, thereby establishing our position in the European cannabis market."

Farmako founder and chief executive officer, Niklas Kouparanis, said, "Signing the first deal in history to sell mass-produced CBD isolate created by biosynthesis to Zenabis is a significant milestone for both Farmako and for the global Cannabis industry. Being the first European company to enter into an agreement to sell CBD isolates to the Canadian market puts Farmako at a significant competitive advantage within the global market and also supports us in bridging the gap between cannabis and pharmaceuticals. With our unique Continuous Bacterial Cannabinoid Biosynthesis (CBCB) method using our patented Bacterium Zynmomonas Cannabinoides®, we are able to produce nature-identical cannabinoids very effectively and at very low costs on a large scale."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the

Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Sign up to get the news alerts including the daily podcast and transcript for Investor ideas podcasts    

Subscribe to the new cannabis podcast series:

https://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Contact Investorideas.com

800-665-0411

  

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directories